{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:23:15Z","timestamp":1785871395041,"version":"3.56.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014571","name":"Alvin J. Siteman Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1053\/j.semdp.2019.04.003","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T02:46:00Z","timestamp":1555382760000},"page":"104-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Molecular biology of human T cell leukemia virus"],"prefix":"10.1053","volume":"37","author":[{"given":"Lee","family":"Ratner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2019.04.003_bib0001","series-title":"Fields virology","first-page":"2071","article-title":"Human T-cell leukemia virus types 1 and 2","author":"Lairmore","year":"2007"},{"key":"10.1053\/j.semdp.2019.04.003_bib0002","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Goncalves","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1053\/j.semdp.2019.04.003_bib0003","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tracli.2015.12.001","article-title":"Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): implications for blood transfusion safety","volume":"23","author":"Murphy","year":"2016","journal-title":"Transfus Clin Biol"},{"key":"10.1053\/j.semdp.2019.04.003_bib0004","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/infdis\/jit497","article-title":"Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors-Unites States, 2000-2009","volume":"209","author":"Chang","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1053\/j.semdp.2019.04.003_bib0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2012.09.035","article-title":"HTLV-3\/4 and simian foamy retroviruses in humans: discovery, epidemiology, cross-species transmission and moleuclar virology","volume":"435","author":"Gessain","year":"2013","journal-title":"Virology"},{"key":"10.1053\/j.semdp.2019.04.003_bib0006","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/v3071131","article-title":"Molecular determinants of human T-lymphotropic virus type 1 transmission and spread","volume":"3","author":"Lairmore","year":"2011","journal-title":"Viruses"},{"key":"10.1053\/j.semdp.2019.04.003_bib0007","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/508899","article-title":"HTLV Outcomes Study (HOST) Investigators. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data","volume":"194","author":"Kwaan","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1053\/j.semdp.2019.04.003_bib0008","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/v3071074","article-title":"HTLV-3\/STLV-3 and HTLV-4 viruses: discovery, epidemiology, seorlogy and molecular aspects","volume":"3","author":"Mahieux","year":"2011","journal-title":"Viruses"},{"key":"10.1053\/j.semdp.2019.04.003_bib0009","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semdp.2019.04.003_bib0010","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2016-09-692574","article-title":"Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells","volume":"129","author":"Watanabe","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.04.003_bib0011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0268-960X(97)90015-1","article-title":"Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis","volume":"11","author":"Ferreira","year":"1997","journal-title":"Blood Rev"},{"key":"10.1053\/j.semdp.2019.04.003_bib0012","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3390\/v2092037","article-title":"Human T lymphotropic virus type 1 (HTLV-1): molecular biology and oncogenesis","volume":"2","author":"Kannian","year":"2010","journal-title":"Viruses"},{"key":"10.1053\/j.semdp.2019.04.003_bib0013","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1111\/febs.14492","article-title":"NF-kB signaling mechanisms in HTLV-1-induced adult T-cell leukemia\/lymphoma","volume":"285","author":"Harhaj","year":"2018","journal-title":"FEBS J"},{"key":"10.1053\/j.semdp.2019.04.003_bib0014","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/v8030058","article-title":"HTLV-1 rex tunes the cellular environment favorable for viral replication","volume":"8","author":"Nakano","year":"2016","journal-title":"Viruses"},{"key":"10.1053\/j.semdp.2019.04.003_bib0015","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3390\/v3060861","article-title":"Orf-1 and orf-II encoded proteins in HTLV-1 infection and persistence","volume":"3","author":"Edwards","year":"2011","journal-title":"Viruses"},{"key":"10.1053\/j.semdp.2019.04.003_bib0016","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/v8030074","article-title":"Molecular mechanisms of HTLV-1 cell-to-cell transmission","volume":"8","author":"Gross","year":"2016","journal-title":"Viruses"},{"key":"10.1053\/j.semdp.2019.04.003_bib0017","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fmicb.2013.00275","article-title":"The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle","volume":"4","author":"Anupam","year":"2013","journal-title":"Front Microbiol"},{"key":"10.1053\/j.semdp.2019.04.003_bib0018","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.mam.2010.03.001","article-title":"HTLV-1 p13, a small protein with a busy agenda","volume":"31","author":"Silic-Benussi","year":"2010","journal-title":"Mol Aspects Med"},{"key":"10.1053\/j.semdp.2019.04.003_bib0019","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12977-016-0249-x","article-title":"Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis","volume":"13","author":"Ma","year":"2016","journal-title":"Retrovirology"},{"key":"10.1053\/j.semdp.2019.04.003_bib0020","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3390\/v3060794","article-title":"Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors","volume":"3","author":"Jones","year":"2011","journal-title":"Viruses"},{"key":"10.1053\/j.semdp.2019.04.003_bib0021","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.3390\/v6114140","article-title":"Integration site and clonal expansion in human chronic retroviral infection and gene therapy","volume":"6","author":"Niederer","year":"2014","journal-title":"Viruses"},{"key":"10.1053\/j.semdp.2019.04.003_bib0022","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fmicb.2018.00449","article-title":"HTLV-1: regulating the balance between proviral latency and reactivation","volume":"9","author":"Kulkarni","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1053\/j.semdp.2019.04.003_bib0023","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fmicb.2014.00302","article-title":"New insights into retroviral Gag-Gag and Gag-membrane interactions","volume":"5","author":"Maldonado","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1053\/j.semdp.2019.04.003_bib0024","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1128\/JVI.02239-09","article-title":"Apobec3G generates nonsense mutations in human T cell leukemia virus type 1 proviral genomes in vivo","volume":"84","author":"Fan","year":"2010","journal-title":"J Virol"},{"key":"10.1053\/j.semdp.2019.04.003_bib0025","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1016\/j.jmb.2013.10.022","article-title":"SAMHD1 host restriction factor: a link with innate immune sensing of retrovirus infection","volume":"425","author":"Sze","year":"2013","journal-title":"J Mol Biol"},{"key":"10.1053\/j.semdp.2019.04.003_bib0026","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1158\/1078-0432.CCR-14-0572","article-title":"Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research","volume":"20","author":"Tsukasaki","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2019.04.003_bib0027","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-4690-5-76","article-title":"The HTLV-I Tax interactome","volume":"5","author":"Boxus","year":"2008","journal-title":"Retrovirology"},{"key":"10.1053\/j.semdp.2019.04.003_bib0028","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12977-014-0116-6","article-title":"Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression","volume":"11","author":"Rowan","year":"2014","journal-title":"Retrovirology"},{"key":"10.1053\/j.semdp.2019.04.003_bib0029","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1742-4690-3-69","article-title":"5\u2032long terminal repeat (LTR)-selective methylation of latently infectd HIV-1 provirus that is demethylated by reactivation signals","volume":"3","author":"Ishida","year":"2006","journal-title":"Retrovirolgy"},{"key":"10.1053\/j.semdp.2019.04.003_bib0030","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1073\/pnas.1419198112","article-title":"TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax","volume":"112","author":"Ma","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1053\/j.semdp.2019.04.003_bib0031","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-4690-10-40","article-title":"LKB1 tumor suppressor and salt-inducible kinases negatively regulate human T-cell leukemia virus type 1 transcription","volume":"10","author":"Tang","year":"2013","journal-title":"Retrovirolgy"},{"key":"10.1053\/j.semdp.2019.04.003_bib0032","doi-asserted-by":"crossref","first-page":"8623","DOI":"10.1128\/JVI.01229-15","article-title":"SIRT1 suppresses human T-cell leukemia virus type 1 transcription","volume":"89","author":"Tang","year":"2015","journal-title":"J Virol"},{"key":"10.1053\/j.semdp.2019.04.003_bib0033","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T-cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2019.04.003_bib0034","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-319-24738-0_4","article-title":"Epigenetic dysregulation in virus-associated neoplasms","volume":"879","author":"Minarovits","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"10.1053\/j.semdp.2019.04.003_bib0035","doi-asserted-by":"crossref","first-page":"36094","DOI":"10.1074\/jbc.M113.485029","article-title":"Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor \u03baB (NF-\u03baB) signaling","volume":"288","author":"Wu","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semdp.2019.04.003_bib0036","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3389\/fmicb.2018.01686","article-title":"HTLV-1-mediated epigenetic pathway to adult T-cell leukemia-lymphoma","volume":"9","author":"Yamagishi","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1053\/j.semdp.2019.04.003_bib0037","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1073\/pnas.1423199113","article-title":"The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome","volume":"113","author":"Satou","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.semdp.2019.04.003_bib0038","doi-asserted-by":"crossref","first-page":"e36245","DOI":"10.7554\/eLife.36245","article-title":"The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis","volume":"7","author":"Melamed","year":"2018","journal-title":"Elife"},{"key":"10.1053\/j.semdp.2019.04.003_bib0039","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3390\/v3060750","article-title":"Controversies in targeted therapy of adult T cell leukemia\/lymnphoma: ON target or OFF target effects?","volume":"3","author":"Nasr","year":"2011","journal-title":"Viruses"},{"key":"10.1053\/j.semdp.2019.04.003_bib0040","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2006-01-0067","article-title":"Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence","volume":"108","author":"Datta","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.04.003_bib0041","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2002-09-2986","article-title":"Arsenic\/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells","volume":"101","author":"Nasr","year":"2003","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1053\/j.semdp.2019.04.003_bib0042","doi-asserted-by":"crossref","first-page":"A59","DOI":"10.1186\/1742-4690-8-S1-A59","article-title":"Arsenic trioxyde in the treatment of HTLV1 associated ATLL","volume":"8","author":"Suarez","year":"2011","journal-title":"Retroviroloogy"},{"key":"10.1053\/j.semdp.2019.04.003_bib0043","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/bjh.13302","article-title":"Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia\/lymphoma in a pilot study","volume":"169","author":"Suehiro","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2019.04.003_bib0044","first-page":"1652","article-title":"HTLV Tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene","volume":"241","author":"Ballard","year":"1988","journal-title":"Science"},{"key":"10.1053\/j.semdp.2019.04.003_bib0045","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V86.11.4063.bloodjournal86114063","article-title":"Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac","volume":"86","author":"Waldmann","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.04.003_bib0046","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V99.5.1505","article-title":"Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells","volume":"99","author":"Yoshie","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.04.003_bib0047","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study","volume":"169","author":"Ishida","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2019.04.003_bib0048","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1517\/13543784.2011.590130","article-title":"Enzastaurin hydrochloride for lymphoma: reassessing the results of clinical trial in light of recent advances in the biology of B-cell malignancies","volume":"20","author":"Ysebaert","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1053\/j.semdp.2019.04.003_bib0049","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1517\/13543784.10.12.2117","article-title":"Protein kinase c inhibitors as novel anticancer drugs","volume":"10","author":"Goekjian","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1053\/j.semdp.2019.04.003_bib0050","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1074\/jbc.RA117.000164","article-title":"An activating mutation of IRF4 unique to adult T cell leukemia","volume":"293","author":"Cherian","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semdp.2019.04.003_bib0051","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2006-07-036368","article-title":"IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia\/lymphoma","volume":"109","author":"Ramos","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.04.003_bib0052","series-title":"Therapeutic targeting of interferon regulatory factor 4 with next generation antisense oligonucleotides produces robust in vivo antitumor activity in preclinical models of multiple myeloma","author":"Zhou","year":"2017"},{"key":"10.1053\/j.semdp.2019.04.003_bib0053","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"key":"10.1053\/j.semdp.2019.04.003_bib0054","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/leu.2012.119","article-title":"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide","volume":"26","author":"Lopez-Girona","year":"2012","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2019.04.003_bib0055","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccell.2018.06.014","article-title":"Targeting the HTLV-1-regulated BATF3\/IRF4 transcriptional network in adult T cell leukemia\/lymphoma","volume":"34","author":"Nakagawa","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1053\/j.semdp.2019.04.003_bib0056","first-page":"E16","article-title":"BET family protein BRD4: an emerging actor in NFkB signaling in inflammation and cancer","volume":"6","author":"Hajimirza","year":"2018","journal-title":"Biomedicine"},{"key":"10.1053\/j.semdp.2019.04.003_bib0057","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1182\/blood-2015-08-662593","article-title":"Polycomb-dependent epigenetic landscape in adult T-cell leukemia","volume":"127","author":"Fujikawa","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.04.003_bib0058","unstructured":"https:\/\/viralzone.expasy.org\/60?outline=all_by_species."}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257019300358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257019300358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:20:06Z","timestamp":1760037606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257019300358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0740257019300358"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2019.04.003","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular biology of human T cell leukemia virus","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2019.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}